XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Aug. 31, 2025
Aug. 31, 2024
Cash provided by operating activities:    
Net (loss) income $ (759,361) $ 23,218
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 26,944 27,628
Amortization of financing costs 764 639
Non-cash operating lease expense 4,336 5,840
Provision for credit losses 342 112
Non-cash share-based compensation 9,668 11,320
Asset impairment charges 740,779 0
Gain on the sale or disposal of property and equipment (75) (29)
Deferred income taxes and tax credits (25,770) 9,039
Changes in operating capital, net of effects of acquisition of business:    
Receivables 77,353 26,340
Inventory (76,278) (73,630)
Prepaid expenses and other current assets (8,006) (5,805)
Other assets and liabilities, net (1,756) (441)
Accounts payable 11,723 78,922
Accrued expenses and other current liabilities 26,378 (22,529)
Accrued income taxes 20,827 (10,708)
Net cash provided by operating activities 47,868 69,916
Cash used by investing activities:    
Capital and intangible asset expenditures (24,832) (14,026)
Net proceeds from business acquired 3,880 0
Payments for purchases of U.S. Treasury Bills (1,387) (1,363)
Proceeds from the maturity of U.S. Treasury Bills 1,275 1,249
Proceeds from the sale of property and equipment 89 39
Net cash used by investing activities (20,975) (14,101)
Cash used by financing activities:    
Proceeds from revolving loans 317,200 509,930
Repayment of revolving loans (583,400) (459,880)
Proceeds from term loans 250,000 0
Repayment of long-term debt (7,031) (3,125)
Payment of financing costs (434) (318)
Proceeds from share issuances under share-based compensation plans 1,757 2,358
Payments for repurchases of common stock (1,482) (103,144)
Net cash used by financing activities (23,390) (54,179)
Net increase in cash and cash equivalents 3,503 1,636
Cash and cash equivalents, beginning balance 18,867 18,501
Cash and cash equivalents, ending balance 22,370 20,137
Supplemental non-cash investing activity:    
Capital expenditures included in accounts payable and accrued expenses $ 7,953 $ 7,767